Diets high in n-3 fatty acids are associated with lower arterial stiffness in patients with rheumatoid arthritis: a latent profile analysis by Woodman, Richard J. et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
1-1-2019 
Diets high in n-3 fatty acids are associated with lower arterial 
stiffness in patients with rheumatoid arthritis: a latent profile 
analysis 
Richard J. Woodman 
Leena R. Baghdadi 
E Michael Shanahan 
Inushi de Silva 
Jonathan M. Hodgson 
Edith Cowan University, jonathan.hodgson@ecu.edu.au 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Biochemical Phenomena, Metabolism, and Nutrition Commons 
10.1017/S0007114518003100 
This article has been published in a revised form as: Woodman, R. J., Baghdadi, L. R., Shanahan, E. M., De Silva, I., 
Hodgson, J. M., & Mangoni, A. A. (2019). Diets high in n-3 fatty acids are associated with lower arterial stiffness in 
patients with rheumatoid arthritis: A latent profile analysis. British Journal of Nutrition, 121(2), 182-194. This 
version is free to view and download for private research and study only. Not for re-distribution, re-sale or use in 
derivative works. © Cambridge University Press. Available here 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/5637 
Authors 
Richard J. Woodman, Leena R. Baghdadi, E Michael Shanahan, Inushi de Silva, Jonathan M. Hodgson, and 
Arduino A. Mangoni 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/5637 
For Review Only
 
 
 
 
 
Diets high in n-3 fatty acids are associated with lower 
arterial stiffness in patients with rheumatoid arthritis: a 
latent profile analysis 
 
 
Journal: British Journal of Nutrition 
Manuscript ID BJN-RA-18-0583.R2 
Manuscript Type: Research Article 
Date Submitted by the Author: n/a 
Complete List of Authors: Woodman, Richard; Flinders University, School of Medicine 
Baghdadi, Leena; King Saud University, Department of Family and 
Community Medicine 
Shanahan, Michael; Flinders University and Southern Adelaide Health 
Network, Department of Rheumatology 
De Silva, Inushi; Flinders University College of Medicine and Public Health, 
Flinders Centre for Epidemiology and Biostatistics 
Hodgson, Jonathan; Edith Cowan University, School of Medical and Health 
Sciences 
Mangoni, Arduino; Flinders University College of Medicine and Public 
Health, Clinical Pharmacology 
Keywords: 
Latent profile analysis, Augmentation index, N-3 fatty acids, Rheumatoid 
arthritis, arterial stiffness 
Subject Category: Human and Clinical Nutrition 
  
 
 
Cambridge University Press
British Journal of Nutrition
For Review Only
Title: Diets high in n-3 fatty acids are associated with lower arterial stiffness in patients with 
rheumatoid arthritis: a latent profile analysis 
Richard J Woodman
1
, Leena R Baghdadi
2
, E Michael Shanahan
3
, Inushi De Silva
1
, Jonathan 
M Hodgson4, Arduino A Mangoni5  
1Centre for Epidemiology and Biostatistics, College of Medicine and Public Health, Flinders 
University, Adelaide, Australia; 2Department of Family and Community Medicine, King Saud 
University, Riyadh, Saudi Arabia; 3Department of Rheumatology, Flinders University and 
Southern Adelaide Local Health Network, Adelaide, Australia. 
4
School of Medical and Health 
Sciences, Edith Cowan University, Perth, Australia. 5Department of Clinical Pharmacology, 
College of Medicine and Public Health, Flinders University and Flinders Medical Centre, 
Adelaide, Australia 
 
 
Corresponding author 
Professor Richard J Woodman, Centre for Epidemiology and Biostatistics, College of 
Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia. Tel: +61 
8 7221 8537, Fax: +61 8 7221 8544, Email: richard.woodman@flinders.edu.au 
Shortened Title: Diet and arterial stiffness in arthritis 
Keywords: Latent profile analysis, augmentation index, n-3 fatty acids, rheumatoid arthritis 
  
Page 1 of 32
Cambridge University Press
British Journal of Nutrition
For Review Only
 2
Abstract 
Supplementation with n-3 fatty acids can influence inflammation and markers of arterial 
stiffness which are increased in patients with rheumatoid arthritis (RA). However, it is 
unknown whether specific patterns of dietary fatty acid intake are similarly associated. In a 
longitudinal study, 86 RA patients reported their dietary intake and had arterial stiffness 
measured using the augmentation index (AIx) at baseline and 8 months.  Latent profile 
analysis (LPA) was performed to characterise patterns of fatty acid intake using 16 major 
fatty acids. Models for 2-6 profiles were compared using the Akaike and Bayesian 
Information Criterion. Associations between AIx and the profiles were adjusted for age, 
gender, disease activity, fish oil supplementation, medications, physical activity and 
socioeconomic status. LPA identified 5 distinct profiles. Profile-1 subjects (n=7) reported 
significantly higher intake of palmitoleic acid (16:1), arachidonic acid (20:4N-6); 
eicosapentaenoic acid (20:5N-3), docosahexaenoic acid (22:6N3), and docosapentaenoic acid 
(22:5N3) (p<0.001 for each) than profiles 2 (n=14), 3 (n=19), 4 (n=23) and 5 (n=23), and 
significantly higher grilled and tinned fish consumption. The AIx varied significantly across 
the 5 profiles (p=0.023); subjects in profile 1 had a significantly lower AIx than those in 
profile 3 (β= -7.2%; 95%CI= -11.5 to -2.9; p=0.001) who had the lowest reported intake of n-
3 fatty acids. Fish oil supplementation was also independently associated with lower AIx (β= 
-4.15%; 95%CI= -6.73 to -1.56; p=0.002). A diet characterised by a higher reported intake of 
N-3’s, palmitoleic acid (16:1) and arachidonic acid (20:4N6) is associated with a lower AIx in 
RA patients.    
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Introduction 1 
Patients with rheumatoid arthritis (RA) are known to have increased systemic inflammation 2 
and arterial stiffness 
(1; 2)
, a process now thought to be a significant contributor in the 3 
development of atherosclerosis and cardiovascular disease (CVD) (3; 4). TNF-alpha antagonists 4 
have been shown to provide a small but significant reduction in aortic stiffness, as measured 5 
by the augmentation index (AIx) using pulse wave analysis, in RA patients (4). This suggests 6 
that pharmacological and, possibly, non-pharmacological interventions might exert beneficial 7 
effects on markers of arterial stiffness, with a consequent reduction in CVD risk in this patient 8 
group.  9 
Dietary fatty acids are a major dietary component and known to influence the cascade of pro- 10 
and anti-inflammatory pr staglandins 
(5)
. In patients with RA, fish oil supplementation has 11 
reduced inflammatory biomarkers (6), disease activity (7) and treatment failure (8). In smokers 12 
(9) and individuals with the metabolic syndrome (10) fish oil supplementation has reduced 13 
markers of systemic inflammation, such as interleukin-6 and TNF-alpha in parallel with 14 
reductions in arterial stiffness. Whether or not certain patterns of fatty acid intake in the diet 15 
are associated with reduced inflammation and central and peripheral arterial wave reflection is 16 
however more difficult to assess. A wide variety of food sources contain high levels of one or 17 
more of the major fatty acids (11), of which a large number are associated with CVD (12) and 18 
each ranges widely between individual’s diets (13). Attempting to determine the independent 19 
associations between each of these fatty acids and measures of arterial stiffness with the use 20 
of multivariate regression models is problematic due multi-collinearity between many of the 21 
fatty acids. In addition, many other known and unknown factors in the diet besides fatty acids 22 
can influence arterial stiffness, creating the potential for residual confounding.  23 
Latent profile analysis (LPA), a special form of latent class analysis (LCA), is an objective 24 
(model-based) data reduction technique that enables the identification of underlying patterns 25 
within data, with each pattern defined by virtue of having similar values across a set of 26 
observed continuous and/or categorical variables (14). LCA can also be thought of as being a 27 
“person-centred” rather than a “variable-centred” approach, since the focus of the analysis is 28 
on identifying groups of individuals with a pattern of similar values, rather than identifying 29 
the effects of each individual variable. LCA thus captures the heterogeneity within and 30 
between groups and can identify the most parsimonious number of distinct patterns in the data 31 
via formal measures of model fit (15).  32 
Page 3 of 32
Cambridge University Press
British Journal of Nutrition
For Review Only
 4
In this study we aimed to identify and describe the unique patterns of dietary fatty acid intake 33 
existing within a representative sample of RA patients that we have previously studied (16). 34 
We then examined which, if any of these patterns were associated with the AIx, a marker of 35 
arterial stiffness and wave reflection, and whether or not there were separate and additive 36 
effects of n-3 fish oil supplementation. In individuals aged 50 and over, aortic arterial wave 37 
reflection measured using the AIx has been found to be a more sensitive marker of arterial 38 
stiffening than pulse wave velocity (17). 39 
 40 
 41 
2. Methods 42 
2. 1 Study design 43 
We conducted a longitudinal study with repeated measurements of reported dietary intake and 44 
AIx at baseline and at 8 months follow-up. LPA was used to determine the major patterns of 45 
dietary fatty acid intake. LPA is a particular form of LCA which can be used to identify 46 
hidden groups from a large number of continuous (LPA) or categorical (LCA) observed 47 
variables (14). The latent (hidden) variable that is formed when using LCA or LPA is 48 
categorical and clusters subjects (or other units) into a small number groups (i.e. classes or 49 
profiles). Our primary interest was to determine the strength of the relationship between these 50 
groups (defined by different patterns of dietary fatty acid intake) and the AIx. Each fatty acid 51 
was measured as a continuous variable in units of grams consumed per day (g/day). We also 52 
assessed the independent association between use of fish oil supplements and the AIx.  53 
 54 
2.2 Patient recruitment and Ethical approval 55 
We studied a consecutive series of patients with stable RA, aged ≥18 years, recruited from the 56 
outpatient clinics of the Rheumatology Department at Flinders Medical Centre and the 57 
Repatriation General Hospital, in the Southern Health Local Heath Network, Adelaide, 58 
Australia. RA was diagnosed according to the 1987 American College of Rheumatology or 59 
the 2010 American College of Rheumatology/European League Against Rheumatism criteria 60 
(18)
. Exclusion criteria were atrial fibrillation, active cancer or current treatment with anti-61 
cancer drugs, heart failure and cognitive impairment. The study (registered in the Australian 62 
New Zealand Clinical Trials Registry with the registration number ACTRN12616001366448) 63 
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was approved by the Southern Adelaide Clinical Human Research Ethics Committee (Ethics 64 
Approval Number: 76.14). Each participant gave written consent before entering the study in 65 
accordance with the Declaration of Helsinki.  66 
 67 
2.3 Augmentation index 68 
AIx (corrected at a heart rate of 75 beats per minute) was measured using Pulse Wave 69 
Analysis (PWA, SphygmoCor version 7.1, AtCor Medical, Sydney, Australia) (19). 70 
Measurement of the AIx was performed at baseline and 8 months. 71 
 72 
2.4 Dietary Fatty acids 73 
Data on reported dietary intake was collected at baseline and 8 months. Nutrient intake from 74 
the diet including fatty acid intake was determined using the validated Dietary Questionnaire 75 
for Epidemiological Studies version 2 (DQES v2) (20; 21; 22). The DQES v2 is a modification of 76 
a food frequency questionnaire (FFQ) that was developed by Cancer Council Victoria in the 77 
late 1980s to measure dietary intake of people taking part in the Melbourne Collaborative 78 
Cohort Study (MCCS). The DQES v2 comprises a food list of 74 items grouped into 4 food 79 
categories; 1. Cereal foods, sweets and snacks, 2. Dairy products, meats and fish, 3. Fruit, 4. 80 
Vegetables. Each item has 10 frequency response options ranging from ‘Never’ to ‘3 or more 81 
times per day’ and a section covering intake of 6 types of alcoholic beverage with 10 82 
frequency response options ranging from ‘never’ to ‘every day’.  The questionnaire also 83 
contains 4 questions that relate to portion size (with regards to potatoes, steak, vegetables, and 84 
meat or vegetable casserole). Responses to these questions are used to calculate a single 85 
portion size factor (PSF) indicating whether on average a person eats median size serves 86 
(PSF=1), more than the median (PSF > 1), or less than the median (PSF < 1). The PSF is used 87 
to scale the standard portion size for different foods up or down, from which energy intake 88 
and nutrient intakes can be calculated for each food frequency item. The questionnaire asks 89 
subjects to describe their intake of food over the preceding 12 months according to food type 90 
and quantity. The data collected by DQES v2 is used to calculate nutrient intakes. The 91 
calculation of the majority of the nutrients is based on Australian nutrient composition data 92 
from NUTTAB95. Calculation of the intakes of individual fatty acids are based on a data set 93 
obtained from Professor Neil Mann, RMIT University, and now used in the FoodWorks 94 
nutrient analysis software. The results from the software analysis provides results that include 95 
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information on total energy intake (kJ/day), saturated fatty acid intake (g/day), 96 
monounsaturated fatty acid intake (g/day), polyunsaturated fatty acid intake (g/day) and the 97 
intake of 30 different fatty acids (g/day) including the 16 major fatty acids included in the 98 
latent profile analysis described in detail below.  99 
 100 
2.5 Clinical and demographic characteristics 101 
The following data were collected from patient interviews, medical questionnaires, clinical 102 
notes, and hospital administrative databases: age, gender, medical and medication history, 103 
weight, height, body mass index (BMI), the 28-joint disease activity score (DAS28) (23), time 104 
spent doing physical activity, level of education, marital status, health insurance status and 105 
income. The DAS28 was measured using high sensitivity C-reactive protein measured at each 106 
time point and erythrocyte sedimentation rate, and swollen and tender joint count taken from 107 
patient notes at the same time-point. Clinic peripheral systolic (SBP) and diastolic (DBP) BP 108 
were measured in the morning, in a quiet environment at room temperature, using the 109 
clinically validated automatic BP monitor (model UA-767PC) (AND Medical, Sydney, 110 
Australia) according to current guidelines (24). High sensitivity C-reactive protein (CRP) was 111 
measured in serum by latex-enhanced immunoturbidimetry on an automated Modular PPE 112 
Analyzer using instrument conditions and reagents supplied by the manufacturer (Roche 113 
Diagnostics) (25).  114 
 115 
2.6 Statistical analysis 116 
Descriptive statistics were used to describe the baseline characteristics of the subjects using 117 
either mean and SD for normally distributed continuous variables, median and inter-quartile 118 
range for non-normally distributed continuous variables and frequency (percentage) for 119 
categorical variables. Correlations between individual fatty acids were estimated using 120 
Pearson’s r correlation coefficient. LPA was performed to identify the pattern of dietary fatty 121 
acid intake using the estimated dietary intakes (in grams/day) of 16 different major fatty acids 122 
(Table 2) obtained from the FFQs and listed as major fatty acids in a recent guide to dietary 123 
reference intakes (28). The LPA was performed using the mean fatty acid intakes recorded 124 
across the 2 visits for each subject, rather than for each visit separately. There were several 125 
reasons for choosing this approach. First, the relatively high within-subject variability of fatty 126 
acid intake across the 2 visits (mean ICC=0.51 between baseline and 8 months) indicated a 127 
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relatively high degree of measurement error of the true average intake. Second, there were 128 
problems with convergence for some of the models when using separate visit data. Third, 129 
averaging the data for the 2 visits meant that each subject was classified with a single latent 130 
profile which assists interpretation of the results. In addition, since intake of fatty acids was 131 
based on g/day, we used energy adjusted intakes for analysis using the nutrient residual 132 
method (29). Briefly, we performed a linear regression of each mean fatty acid on mean daily 133 
energy intake and used the resulting residuals as the new variables for the LPA. Models were 134 
estimated for between 2 and 6 latent profiles, and for each model the profile membership of 135 
each subject was decided based their highest (posterior) predicted probability of profile 136 
membership. Model fit was based on the Akaike Information Criterion (AIC) and the 137 
Bayesian Information Criterion (BIC). The selected model was based on both model fit 138 
(lowest AIC and BIC), and consideration of the number of subjects assigned to each profile (a 139 
minimum of 5 subjects) since 5% of subjects per profile is a good rule of thumb (30). Line 140 
plots of the standardised energy adjusted fatty acid intake for the 16 FA’s were used to 141 
identify the main fatty acids charact rising each profile. Standardisation of the fatty acids i.e. 142 
calculating a z-score, was performed to ease interpretation since absolute fatty acid intakes 143 
vary considerably across the range of fatty acids. Mean differences in the 16 FAs across the 144 
profiles were compared using linear regression with additional adjustment for energy intake 145 
(29). We compared the AIx across latent profiles using linear mixed effects univariate and 146 
multivariate regression with adjustment for age, gender, BMI, visit (baseline or 8 months), 147 
DAS28, use of ibuprofen, use of folic acid, use of methotrexate, energy intake, hours of 148 
physical activity per week, income, level of education, marital status, and private health 149 
insurance status. The subject was included in the model as a random intercept. We also 150 
compared SBP, DBP and log10-transformed CRP across latent profiles using the same 151 
approach. In each of these models we assessed the overall significance of the profile variable 152 
using a Wald test that compared models with and without the profile variable. Finally for 153 
comparison purposes, we assessed the association between AIx and each individual fatty acid 154 
using the same univariate and multivariate mixed effects regression with the same adjustment 155 
as above. 156 
Analysis was performed using STATA (StataCorp, version 15.1, USA) and R software (for 157 
figures). The LPA was performed using the STATA “gsem” command for generalised 158 
structural equation modelling, for which latent class analysis was incorporated in version 15. 159 
A type 1 error rate of α=0.05 was considered statistically significant for all regression 160 
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analyses. Based on a Bonferroni correction, a type 1 error rate of p=0.001 was considered 161 
significant when comparing the 16 individual fatty acid intakes across profiles. 162 
 163 
1. Results 164 
1. Clinical and demographic characteristics and fatty acid intake 165 
A total of 86 subjects were recruited and measures of diet and AIx were recorded at baseline 166 
and after 8 months. The baseline characteristics of the subjects are described in Table 1. The 167 
median (IQR) age of the subjects was 64 (56-69) and 63 (73.3%) were female. The reported 168 
mean fatty acid intake (g/day) and correlations between the fatty acids are described in Table 169 
2. There was a high correlation between the saturated fatty acids, between the mono- and 170 
poly-unsaturated fats (palmitoleic acid (16:1), oleic acid (18:1) and linoleic acid (18:2)) and 171 
between the n-3 fatty acids. 172 
 173 
2. Latent profile analysis 174 
All 86 subjects completed dietary assessments at baseline and 79 subjects completed dietary 175 
assessment at 8 months. All LPA analyses with 2, 3, 4, 5 and 6 specified latent profiles 176 
converged successfully and the AIC and BIC statistics for these are described in Table 3. 177 
Based on the lowest BIC, the optimal number of classes was 5. The mean probability of 178 
accurately assigned profile membership ranged from 0.94 for profile 4 to 1.00 for profile 1 179 
(Table 4) indicating a high degree of certainty that each individual was assigned to the correct 180 
dietary fatty acid pattern.  181 
 182 
3. Fatty acid intakes and food frequencies 183 
Figure 1 and Table 5 describe the standardised mean fatty acid intake according to each of the 184 
5 dietary patterns. There were overall significant differences (p<0.001) across the 5 patterns 185 
for 15 of the 16 fatty acids (all except 18:2 n-6 Trans) (Table 5). In particular, profiles 2, 3, 4 186 
and 5 were significantly lower than profile 1 for palmitoleic acid (16:1), eicosapentaenoic 187 
acid (20:5-n3), docosahexaenoic acid (22:6n-3) (p<0.001) and docosapentaenoic acid (22:5 n-188 
3) (p<0.001 for each except; p=0.007 for 16:1 profile 3 vs profile 1) (Figure 1). Profile 1 had 189 
the highest reported intake for each of these fatty acids and profile 3 generally the lowest 190 
reported intake. Figure 2 displays each individual’s fatty acid intake together with the mean 191 
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reported intake for the 5 profiles. The mean reported intake for fish, meats and the frequency 192 
distribution of the “usual fat spread used on bread” according to the 5 profiles are described in 193 
Table 6. There were no significant differences across profiles for fried fish (p=0.08). 194 
However, reported intake of grilled fish, tinned fish and total fish were significantly higher 195 
amongst subjects in profile 1 (p<0.001 for each). Profile 1 had the highest reported intake for 196 
each, whilst profile 3 had the lowest reported intake for each. There were no significant 197 
differences across the 5 profiles for each of beef, veal, chicken, lamb, pork, bacon, ham, beef 198 
salami, sausages or total meat (p>0.05 for each). There was a significant difference across the 199 
5 profiles in the main choice of fat spread used on bread (p<0.001). The most common spread 200 
for profiles 1 and 5 was “Butter” (28.6% and 53.3% respectively) whilst the most common 201 
spread for profiles 2, 3 and 4 was “None”, “None” and “Poly margarine” (36.0%, 42.1% and 202 
34.9% respectively).  203 
 204 
4. Multilevel regression for AIx75, CRP and clinic BP on latent profiles 205 
A total of n=165 observations were included in the mixed effects linear regression analysis for 206 
AIx with 79 subjects providing data at both baseline and 8 months and a further 7 subjects 207 
providing data at baseline alone. There were 5 subjects that did not have AIx measured at 208 
either baseline or 8 months and were therefore excluded from the analysis for AIx. 209 
In univariate analysis, there was an overall non-significant difference (p=0.600) across 210 
profiles in the mean AIx (Table 7A). However, after adjustment for age, gender, BMI, time 211 
(baseline or 8 months), DAS28, ibuprofen, folic acid, methotrexate, physical activity, income,  212 
education, health insurance status, marital status and fish oil, the mean AIx was significantly 213 
different across profiles overall (p=0.023). In particular, subjects in profile 1 (high in n-3’s, 214 
16:1 and 20:4) had lower AIx than subjects in profile 3 (β= -7.2%, 95% CI= -11.5 to -2.9; 215 
p=0.001) (Table 7A). In addition, fish oil supplementation was an independent predictor of 216 
lower AIx (β=-4.15, 95% CI= -6.73 to -1.56; p=0.002). In contrast, older age (p=0.028), 217 
female gender (<0.001), and higher BMI (0.021) were independent predictors of a higher AIx 218 
(Table 7A). 219 
In both univariate and multivariate analysis, there was no overall significant difference in log-220 
transformed CRP across the 4 profiles (p=0.99 and p=0.89 respectively) (Table 7B). 221 
However, higher DAS28 was independently associated with higher CRP (p<0.001) (Table 222 
7B).  223 
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In multivariate analysis of clinic blood pressure, there was no overall difference between 224 
profiles for either SBP (p=0.197) or DBP (p=0.308).  225 
5. Multilevel regression for AIx75 on individual fatty acids 226 
Table 7C shows the results of the univariate and multivariate mixed effects regression for AIx 227 
and each of the 16 individual fatty acids. There were no significant associations for any of the 228 
fatty acids in either the univariate or multivariate analysis. 229 
 230 
Discussion 231 
In this study we used LPA to identify 5 underlying patterns of dietary fatty acid intake that 232 
were present within a population of patients with RA. Together with multivariate regression 233 
analysis, the LPA methodology allowed us to associate patterns of reported dietary fatty acid 234 
intake with the AIx measured using pulse wave analysis. Such associations were not present 235 
when fatty acids were assessed individually suggesting that the aggregated information 236 
obtained from an  LPA approach was better able to recover relevant information on fatty acid 237 
intake. Subjects with diets classified as being within fatty-acid profile 1, characterised by a 238 
high level of n-3 fatty acids, palmitoleic acid (16:1) and arachidonic acid (20:4 n-6), had a 239 
significantly lower AIx than subjects within profiles 2 and 3, both of which had lower levels 240 
of n-3 fatty acids. Profile 2 also had lower levels of palmitic acid (16:0), palmitoleic acid 241 
(16:1) and oleic acid (18:1) than profile 1, and profile 5 had higher levels of all saturated fatty 242 
acids, and lower levels of palmitoleic acid (16:1) and linoleic acid (18:2 n-6). Profile 4 was 243 
the only group with higher levels of trans fatty acids. The adjusted difference in AIx between 244 
groups 1 and 3 was 7.18%, much larger than the mean 1.48% difference recently observed in 245 
a meta-analysis of RCT’s for patients with RA using TNF-alpha antagonists (4). When 246 
comparing food consumption across the 5 profiles, profile 1 subjects had a similar reported 247 
mean meat intake compared to other profiles, but had much higher levels of grilled and tinned 248 
fish consumption. There were also small but significant differences in their usual choice of 249 
spreads for bread, with profile 1 having a higher use of monounsaturated margarines (21% 250 
versus 4% overall), and moderate but non-significantly higher levels of chicken and egg 251 
consumption.  252 
In addition to observing a lower AIx for subjects with overall higher fish intake, there was an 253 
independent and additive effect of n-3 supplementation with the AIx. This supports the 254 
findings of higher reported n-3 intake from the diet being associated with lower AIx, and also 255 
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suggests that a dose-response n-3 intake may exist. A reduction in arterial wave reflection 256 
following n-3 supplementation has been observed in smokers (9),  but there was no change in 257 
AIx with 12 weeks of 4g/day of n-3 supplementation daily amongst both young and older 258 
healthy subjects (31). Similarly, there was no association between serum n-3 fatty acids and 259 
arterial wave reflection in healthy Japanese men (32). Together these studies and our study 260 
suggest that the benefits of n-3 supplementation in preventing increased arterial stiffening and 261 
wave reflection may be most apparent in individuals at greater CVD risk. 262 
Inflammation is known to contribute to arterial stiffening both directly (3; 33), and indirectly, 263 
via aging, diabetes and CVD (34), and n-3 fatty acids can reduce inflammation (6; 9; 10). 264 
However, we observed no association between CRP and the AIx. It is therefore possible that 265 
the differences we observed in AIx between the 5 groups was mediated directly via other 266 
CVD protective effects of fish oil (35) rather than indirectly via their effects on inflammation. 267 
In particular, fish oil is known to influence the production of nitric oxide, improving 268 
endothelial function and vasodilatation, as well as lowering triglycerides, remnant 269 
lipoproteins and platelets (36). 270 
In addition to being high in n-3 fatty acids, profile 1 was also characterised by higher levels of 271 
palmitoleic acid (16:1) and arachidonic acid (20:4 n-6). Whilst fish intake contributes to both 272 
of these, particularly palmitoleic acid (16:1), the major contributors to arachidonic acid (20:4 273 
n-6) in the diet in the general population are chicken (26.9%), eggs (17.8%), beef (7.3%), 274 
sausage and bacon (6.7%) and fish (5.8%) 
(37)
. There were no significant differences between 275 
profiles in regards to the mean reported intake of chicken, eggs, beef and sausage, although all 276 
were slightly higher in profile 1 compared to other profiles, and in particular chicken and 277 
eggs. We can conclude therefore that in addition to fish, a higher consumption of eggs and 278 
chicken would have partly contributed towards a higher level of arachidonic acid (20:4 n-6) 279 
for profile 1. Arachidonic acid (20:4 n-6) is an essential fatty acid and precursor for the 280 
production of inflammatory prostaglandins, and together with the N-3 fatty acids, helps 281 
modulate inflammation (5). There is still debate as to whether or not a higher intake of n-6 282 
fatty acids in general is beneficial or detrimental in regards to reducing risk for CVD (38). 283 
Whilst the American Heart Association has previously given advice to consume at least 5-284 
10% of energy as n-6 polyunsaturated fatty acids in order to reduce heart disease (39), much of 285 
the evidence for this advice was based on intervention trials that increased the intake of 286 
linoleic acid, the predominant n-6 fatty acid in the Western diet. However, many of the 287 
interventions for these trials also increased consumption of n-3 fatty acids (both alpha-288 
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linolenic acid and/or marine n-3 fatty acids, and also restricted the intake of trans-fatty acids) 289 
(38). In addition, too little attention was paid to the individual fatty acids within the n-6 intake, 290 
assuming instead that their effects could be considered equivalent. A call was therefore made 291 
for greater focus on specific fatty acids and absolute amounts/concentrations rather than on 292 
fatty acid classes and ratios (38). Given that our study demonstrated reduced arterial stiffness 293 
amongst a group of individuals with a significantly higher reported intake of arachidonic acid 294 
(20:4 n-6), it provides at least some reassurance as to the safety of such a diet, perhaps with 295 
the caution that it should be followed in conjunction with a high marine n-3 fatty acid intake.  296 
Strengths of this study included the use of LPA which allowed us to identify the main patterns 297 
of reported dietary fatty acid intake, and the use of these as a single dietary exposure variable 298 
rather than many individual fatty acids either alone or together. When we assessed the 299 
individual fatty acids alone, we found no associations with the AIx. Grouping subjects 300 
according to their dietary fatty acid patterns also allowed us to explore which foods were 301 
consumed differently across the 5 groups and thereby which were most likely to be 302 
responsible for the separate fatty acid patterns. Identifying the specific food groups that 303 
contribute to the dietary patterns is also important to help provide practical dietary 304 
recommendations. Our dataset was also well described and this allowed us to adjust our 305 
analysis for important confounders including age, gender, BMI, various medications, 306 
socioeconomic status, and physical activity that each might have been associated with diet 307 
quality as well as underlying cardiovascular disease. Except for age, gender and BMI, these 308 
variables were not significantly associated with the AIx and did not therefore substantively 309 
alter our conclusions. Finally, we adjusted for energy intake to ensure that differences in 310 
absolute fatty acid intake (g/day) between the profiles was not simply a result of differences 311 
in total food consumption. 312 
Limitations to our study include its observational nature and cross sectional design which 313 
therefore precludes making causal inferences. It is possible for example, that subjects with 314 
higher arterial wave reflection may have known they were at a higher risk of CVD and may 315 
have altered their diet to one that included more fish and/or n-3 supplements. However the 316 
possibility of reverse causality is low given that much of the population in general, including 317 
those with increased CVD risk, consume less fish than recommended (40), despite its known 318 
health benefits. The prevalence of high fish consumption in our study population was also 319 
similar to those aged ≥ 65 years in the Australian general population (40). There is also the 320 
possibility that our results were subject to residual confounding by factors that may influence 321 
both diet and arterial wave reflection. A healthier diet, and in particular one that is high in n-3 322 
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fatty acids, is often a marker of a healthier lifestyle in general, including higher levels of 323 
exercise and lower bodyweight. We therefore adjusted for a wide number of possible 324 
confounders including exercise, BMI, gender, and several well-established measures of 325 
socioeconomic status including level of education, income and marital status. However, our 326 
exercise measure only captured the time spent doing physical activity and not intensity. As 327 
such, it may not have completely removed the influence of each individual’s physical activity 328 
on arterial stiffness. In addition, a diet high in n-3 fatty acids might also be higher in other 329 
nutrients that themselves can influence arterial function and stiffness including flavonoids (41) 330 
and Vitamin D (42) respectively, with the n-3 fatty acid profile perhaps therefore acting partly 331 
as a marker for these nutrients. A further limitation was the reliance on self-reported food 332 
intake for the estimation of fatty acid intake rather than the use of measured food records or 333 
tissue data (plasma or rood blood cells). The latter would provide a more accurate assessment 334 
of fatty acid intake from the diet in the short and medium term respectively, and would also 335 
not be subject to memory bias. However, the collection of dietary data at repeated time-points 336 
rather than a single time-point has previously been shown to increase explanatory power (43) 337 
indicating a reduction in measurement error. In addition, the use of food frequency 338 
questionnaires has been shown to give reasonably valid measures of fatty acid intake 
(44)
. Our 339 
food frequency questionnaire did not query the type or quantity of oils or creams used in 340 
cooking information, which might potentially have had a large impact on fatty acid intake and 341 
accurate profile classification. Finally, whilst our results were more informative than those 342 
obtained from univariate and multivariate regression for each fatty acid, we did not compare 343 
our findings with other clustering techniques such as k-means clustering. Such approaches 344 
may also be useful in identifying similar dietary behaviours, albeit without objective guidance 345 
from model based statistics including the AIC and BIC. 346 
In conclusion, the use of latent profile analysis successfully identified 5 main patterns of 347 
dietary fatty acid intake amongst subjects with RA using the nutrient data obtained from 348 
repeat dietary food intake questionnaires. Subjects with a dietary fatty acid profile 349 
characterised by a high reported intake of N-3’s, palmitoleic acid (16:1) and arachidonic acid 350 
(20:4 n-6) and reflecting a significantly higher reported fish intake, had significantly lower 351 
AIx than subjects with the lowest reported intake of N-3 fatty acids. This was independent of 352 
a similar association with fish-oil. Together these findings suggest that n-3 fatty acids are the 353 
predominant fatty acids associated with reduced arterial wave reflection. By adhering to a diet 354 
high in fish with the possible addition of n-3 supplements, RA patients might help slow the 355 
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progression of arterial aging and the consequent increase in CVD risk. However, this 356 
hypothesis needs to be further investigated in interventional studies.  357 
 358 
  359 
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Table 1: Baseline clinical characteristics of the study population (n=86) 
 All subjects 
(n=86) 
Profile 1 
(n=7) 
Profile 2 
(n=14) 
Profile 3 
(n=19) 
Profile 4 
(n=23) 
Profile 5 
(n=23) 
p-value
1
 
Age (years), median(IQR) 64 (56-69) 61 (52-68) 69 (64-73) 64 (58-69) 61 (51-68) 64 (56-75) 0.52 
Male/Female, n (%) 23/63 (27/73) 1/6 (14/86) 5/9 (36/64) 5/14 (26/74) 6/17 (26/74) 6/17 (26/74) 0.92 
BMI (kg/m2), median(IQR) 26.6 (23.1-31.1) 27.7 (23.7-39.5) 23.4 (21.5-27.2) 28.8 (23.9-32.0) 26.0 (23.1-31.1) 27.0 (24.9-30.5) 0.30 
DAS28, mean±SD 3.1±1.2 3.0±1.3 3.1±1.1 3.4±1.5 2.8±1.4 3.0±0.9 0.62 
C-reactive protein (mg/L), median(IQR) 2.1 (0.8-4.9) 3.7 (0.2-12.0) 1.8 (1.5-6.9) 2.0 (0.6-4.8) 2.1 (1.0-4.7) 2.5 (0.8-4.2) 0.72 
Clinic SBP (mmHg), median(IQR) 125 (115-134) 115 (108-125) 122 (112-143) 129 (120-138) 127 (115-134) 125 (114-137) 0.32 
Clinic DBP (mmHg), mean±SD 75±11 72±5 71±17 78±9 74±11 77±10 0.38 
AIx75 (%), mean±SD 28.7±6.7 24.3±9.4 29.2±7.6 29.1±7.0 29.7±5.2 28.5±6.5 0.47 
Methotrexate use, n (%) 56 (65.1) 4 (57.1) 11 (78.6) 10 (52.6) 16 (69.6) 15 (65.2) 0.59 
Prednisolone use, n (%) 30 (34.9) 2 (28.6) 6 (42.9) 7 (36.8) 9 (39.1) 6 (26.1) 0.85 
Ibuprofen use, n (%) 7 (8.1) 0 (0.0) 1 (7.1) 2 (10.5) 2 (8.7) 2 (8.7) 1.00 
Folic acid use, n (%) 46 (53.5) 4 (57.1) 10 (71.4) 8 (42.1) 13 (56.5) 11 (47.8) 0.54 
Fish Oil use, n (%) 26 (30.2) 3 (42.9) 5 (35.7) 7 (36.8) 7 (30.4) 4 (17.4) 0.54 
Level of education, n (%) 
   Primary school 
   Secondary school 
   Bachelor degree 
   Above bachelor degree 
   Vocational education 
   None 
Income, n (%) 
   AUD$0-AUD$24,999 
 
2 (2.3) 
53 (61.6) 
14 (16.3) 
5 (5.8) 
10 (11.6) 
2 (2.3) 
 
44 (51.2) 
 
0 (0.0) 
5 (71.4) 
2 (28.6) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
 
3 (42.9) 
 
0 (0.0) 
11 (78.6) 
3 (21.4) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
 
8 (57.1) 
 
1 (5.3) 
7 (36.8) 
5 (26.3) 
2 (10.5) 
4 (21.0) 
0 (0.0) 
 
5 (26.3) 
 
12 (52.2) 
5 (21.7) 
3 (13.0) 
2 (8.7) 
1 (4.3) 
1 (4.3) 
 
12 (52.2) 
 
16 (69.6) 
3 (13.0) 
1 (4.35) 
1 (4.35) 
1 (4.35) 
1 (4.35) 
 
16 (69.6) 
 
0.34 
 
 
 
 
 
 
0.31 
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   AUD$25,000-AUD$49,999 
   AUD$50,000-AUD$74,999 
   AUD$75,000-AUD$99,999 
   AUD$100,000-AUD$124,999 
   AUD$150,000-AUD$174,999    
20 (23.3) 
13 (15.1) 
5 (5.8) 
3 (3.5) 
1 (1.6) 
2 (28.6) 
1 (14.3) 
1 (14.3) 
0 (0.0) 
0 (0.0) 
2 (14.3) 
3 (21.4) 
1 (7.1) 
0 (0.0) 
0 (0.0) 
8 (42.1) 
5 (26.3) 
0 (0.0) 
1 (5.3) 
0 (0.0) 
5 (21.7) 
3 (13.0) 
2 (8.7) 
1 (4.35) 
0 (0.0) 
3 (13.0) 
1 (4.35) 
1 (4.35) 
1 (4.35) 
1 (4.35) 
Physical activity (min/week), median (IQR) 180 (60-360) 180 (60-360) 180 (60-420) 180 (60-480) 180 (90-360) 240 (30-360) 0.48 
Private Health Insurance, Yes (%) 49 (57.0) 5 (71.4) 9 (64.3) 11 (57.9) 13 (56.5) 11 (47.8) 0.81 
Marital status, n (%) 
   Married 
   Divorced/Separated 
   Widowed 
   Never married 
 
55 (64.0) 
11 (12.8) 
12 (14.0) 
1 (14.3) 
 
3 (42.9) 
1 (14.3) 
2 (28.6) 
1 (14.3) 
 
8 (57.1) 
1 (7.1) 
3 (21.4) 
2 (14.3) 
 
13 (68.4) 
4 (21.0) 
1 (5.3) 
1 (5.3) 
 
15 (65.2)  
5 (21.7) 
3 (13.0) 
0 (0.0) 
 
16 (69.6) 
0 (0.0) 
3 (13.0) 
4 (17.8) 
 
0.15 
 
 
 
Energy intake (kJ/day), median(IQR) 5,596 (4,079-
7,973) 
6,651 (5,192-
9,610) 
6,162 (4,752-
8,229) 
5,034 (4,214-
6,529) 
5,079 (4,050-
6,486) 
5,900 (4,899-
8,228) 
0.39 
Total fat (g/day), median(IQR) 53.1 (37.5-79.6) 93.8 (59.8-115.5) 43.9 (24.0-79.6) 44.0 (29.3-62.0) 53.3 (32.7-81.4) 67.0 (42.9-85.9) 0.08 
Monounsaturated fats (g/day), median(IQR)  18.0 (12.5-29.1) 36.9 (18.2-46.2) 14.8 (8.5-28.1) 16.0 (11.3-23.0) 18.9 (12.1-29.1) 23.3 (14.5-28.1) 0.006 
Saturated fats (g/day), median(IQR) 23.0 (14.0-33.7) 28.5 (27.2-38.2) 16.1 (9.7-27.9) 15.8 (11.7-24.1) 21.7 (11.8-30.2) 30.6 (19.7-40.3) 0.246 
Polyunsaturated fats (g/day), median(IQR) 7.7 (5.0-11.7) 15.0 (5.5-22.5) 7.6 (3.4-11.9) 6.5 (4.5-8.6) 8.3 (7.0-13.6) 6.9 (4.4-9.9) 0.025 
1P-value for difference between profiles using ANOVA (normal distributions), test of medians (asymmetric distributions) or Fishers Exact (categorical). 
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Table 2A: Mean dietary fatty acid intake and Pearson’s r correlations amongst the 16 dietary fatty acids (n=86). 
  
Dietary Fatty acid 
Mean±SD 
(g/day) 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
14 
 
15 
1 8:0 Caprylic acid 0.30±0.18 1.00               
2 10:0 Caproic acid 0.50±0.31 0.97 1.00              
3 12:0 Lauric acid 1.32±0.81 0.97 0.89 1.00             
4 14:0 Myristic acid 2.77±1.57 0.91 0.96 0.86 1.00            
5 16:0 Palmitic acid 13.75±6.60 0.88 0.88 0.86 0.94 1.00           
6 18:0 Stearic acid 7.09±3.87 0.90 0.88 0.87 0.92 0.98 1.00          
7 16:1 Palmitoleic acid 1.50±0.71 0.61 0.63 0.57 0.74 0.88 0.82 1.00         
8 18:1 Oleic acid 21.01±9.64 0.79 0.78 0.78 0.84 0.97 0.94 0.90 1.00        
9 18:2 Linoleic acid 7.22±3.39 0.50 0.45 0.52 0.46 0.64 0.58 0.58 0.76 1.00       
10 18:1; trans 0.45±0.38 0.59 0.61 0.61 0.68 0.61 0.59 0.34 0.54 0.50 1.00      
11 18:2; trans 0.006±0.010 0.12 0.10 0.12 0.04 0.09 0.05 0.01 0.10 0.23 0.36 1.00     
12 20:4 n-6 (AA) 0.065±0.045 0.21 0.23 0.18 0.35 0.43 0.35 0.64 0.49 0.34 0.02 -0.08 1.00    
13 18:3 n-3 (LA) 0.79±0.38 0.73 0.70 0.75 0.74 0.87 0.84 0.76 0.91 0.82 0.64 0.22 0.37 1.00   
14 20:5 n-3 (EPA) 0.139±0.169 -0.02 -0.02 -0.01 0.08 0.14 0.05 0.38 0.20 0.21 -0.12 -0.10 0.85 0.17 1.00  
15 22:6 n-3 (DHA) 0.287±0.332 -0.01 -0.02 -0.01 0.09 0.15 0.06 0.40 0.22 0.22 -0.12 -0.10 0.86 1.00 0.99 1.00 
16 22:5 n-3 (DPA) 0.048±0.050 0.04 0.04 0.03 0.14 0.21 0.13 0.46 0.28 0.25 -0.09 -0.11 0.90 0.22 0.98 0.99 
Bold indicates correlations which are statistically significant (p<0.05). AA=Arachidonic acid, LA=alpha-linolenic acid, EPA=eicosapentaenoic 
acid, DHA=docosahexaenoic acid, DPA=docosapentaenoic acid.  
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Table 3: Model fit statistics and profile membership distribution 
   Number of subjects in each profile 
Model AIC BIC Profile 1 Profile 2 Profile 3 Profile 4 Profile 5 Profile 6 
1-profile 674.0 752.5 86      
2-profile 442.3 562.6 47 39     
3-profile 173.5 338.0 7 47 32    
4-profile 121.0 329.6 7 32 24 23   
5-profile 44.8 292.7 7 14 19 23 23  
6-profile 57.7 335.0 6 15 19 22 21 3 
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Table 4: Mean posterior probabilities associated with profile membership in the 5-profile 
LCA model 
  Probability of membership in each profile  
Assigned fatty acid profile n Profile-1 Profile-2 Profile-3 Profile-4 Profile-5 
Profile-1 7 1.00 0.00 0.00 0.00 0.00 
Profile-2 14 0.00 0.99 0.01 0.00 0.00 
Profile-3 19 0.00 0.03 0.95 0.02 0.00 
Profile-4 23 0.00 0.01 0.02 0.94 0.03 
Profile-5   23 0.00 0.00 0.00 0.02 0.98 
 
  
Page 23 of 32
Cambridge University Press
British Journal of Nutrition
For Review Only
 24
Table 5: Energy adjusted mean standardised fatty acid intakes according to latent profile 
   
 
n 
Profile 1 
(n=7) 
Mean±SD 
Profile 2 
(n=14) 
Mean±SD 
Profile 3 
(n=19) 
Mean±SD 
Profile 4 
(n=23) 
Mean±SD 
Profile 5 
(n=23) 
Mean±SD 
 
 
p-value
1
 
1 8:0 Caprylic acid 86 -1.11±0.86 -0.54±0.55 -0.62±0.52 0.01±0.49 1.17±0.82 <0.001 
2 10:0 Caproic acid 86 -1.05±1.14 -0.37±0.64 -0.68±0.59 -0.03±0.53 1.14±0.72 <0.001 
3 12:0 Lauric acid 86 -1.11±0.95 -0.64±0.41 -0.55±0.50 0.12±0.61 1.06±0.91 <0.001 
4 14:0 Myristic acid 86 -0.62±1.45 -0.69±0.80 -0.58±0.51 -0.01±0.60 1.10±0.60 <0.001 
5 16:0 Palmitic acid 86 -0.20±1.35 -1.37±0.63 -0.34±0.46 0.23±0.49 0.94±0.65 <0.001 
6 18:0 Stearic acid 86 -0.65±1.32 -1.15±0.69 -0.39±0.47 0.29±0.55 0.93±0.71 <0.001 
7 18:1 Trans 86 -0.77±1.25 0.07±0.78 -0.69±0.45 0.52±0.86 0.24±1.10 0.001 
8 18:2 n-6 Trans 86 -0.38±0.78 0.18±1.29 -0.18±0.59 0.28±1.19 -0.13±0.91 0.38 
9 16:1 Palmitoleic acid 86 1.44±1.22 -1.05±0.65 0.48±0.69 -0.20±0.63 0.01±0.90 <0.001 
10 18:1 Oleic acid 86 0.69±1.74 -1.47±0.61 -0.05±0.62 0.45±0.53 0.27±0.65 <0.001 
11 18:2 Linoleic acid 86 0.66±1.75 -0.12±1.20 -0.25±0.51 0.68±0.76 -0.61±0.55 <0.001 
12 18:3 n-3 (LA) 86 0.37±1.04 -0.68±0.69 -0.58±0.30 0.86±1.22 -0.08±0.58 <0.001 
13 20:4 n-6 (AA) 86 2.53±1.20 -0.66±0.43 0.44±0.37 -0.42±0.56 -0.31±0.41 <0.001 
14 20:5 n-3 (EPA) 86 2.62±1.61 -0.43±0.39 0.23±0.50 -0.39±0.32 -0.34±0.36 <0.001 
15 22:6 n-3 (DHA) 86 2.63±1.60 -0.44±0.39 0.25±0.49 -0.39±0.32 -0.35±0.34 <0.001 
16 22:5 n-3 (DPA) 86 2.60±1.68 -0.43±0.43 0.25±0.37 -0.39±0.35 -0.34±0.39 <0.001 
Values in bold indicate statistical significance (p=0.001) compared to Profile 1. 1P-value 
across the 5 profiles. AA=Arachidonic acid, LA=alpha-linolenic acid, EPA=eicosapentaenoic 
acid, DHA=docosahexaenoic acid, DPA=docosapentaenoic acid. 
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Table 6. Selected food frequencies across the 2 visits by latent profile, n=86 subjects and n=165 records 
  Profile 1 Profile 2 Profile 3 Profile 4 Profile 5 p-value
1
 
 Scale (Mean±SD) (Mean±SD) (Mean±SD) (Mean±SD) (Mean±SD)  
Fish fried 1 to 10 2.92±2.02 1.76±0.97 2.03±1.40 1.93±1.08 2.31±1.24 0.17 
Fish tinned 1 to 10 7.00±1.84 3.00±1.71 4.34±1.81 2.74±1.35 3.18±1.20 <0.001 
Fish grilled 1 to 10 5.71±2.40 3.36±1.78 4.21±1.12 3.12±1.48 3.40±1.27 <0.001 
Total fish 3 to 30 15.64±4.24 8.12±3.22 10.58±2.72 7.79±2.33 8.89±2.40 <0.001 
Beef 1 to 10 4.86±2.03 3.36±1.32 3.71±1.45 3.88±1.73 3.82±1.59 0.34 
Veal 1 to 10 1.86±2.18 1.88±1.09 1.66±1.26 1.84±1.23 2.42±1.39 0.43 
Chicken 1 to 10 4.93±2.16 4.20±1.63 5.00±1.43 4.23±1.72 4.60±1.14 0.29 
Lamb 1 to 10 3.36±2.02 2.68±1.28 3.32±1.86 3.40±1.55 3.76±1.49 0.31 
Pork 1 to 10 2.79±2.15 2.32±1.80 3.00±1.77 2.16±1.34 2.84±1.33 0.44 
Bacon 1 to 10 3.64±2.13 2.28±1.31 2.76±1.44 2.33±1.13 3.16±1.51 0.08 
Ham 1 to 10 3.29±2.05 2.60±1.44 2.95±1.52 3.12±1.52 3.96±1.48 0.06 
Beef Salami 1 to 10 2.71±2.05 2.08±1.22 2.47±1.87 1.84±1.21 3.00±1.80 0.10 
Sausages 1 to 10 2.64±2.24 1.80±0.96 2.08±1.19 2.58±1.65 2.64±1.19 0.27 
Total meat 9 to 90 30.1±15.9 23.2±8.1 26.95±7.5 25.4±8.6 30.2±6.7 0.14 
Eggs per week 1 to 5 3.57±1.34 2.80±0.0.58 3.47±0.86 2.72±1.10 2.93±0.89 0.005 
Nuts 1 to 10 7.00±2.25 3.72±2.42 4.84±2.54 4.58±2.54 3.11±2.07 <0.001 
Peanut Butter 1 to 10 2.21±1.58 2.24±1.96 2.18±1.77 2.19±1.72 1.76±1.30 0.826 
Usual spread on        
Page 25 of 32
Cambridge University Press
British Journal of Nutrition
For Review Only
 26
bread (choice of one) N (%) N (%) N (%) N (%) N (%) p-value2 
   None  2 (14.3) 9 (36.0) 16 (42.1) 6 (13.9) 2 (4.4) <0.001 
   Margarine  2 (14.3) 5 (20.0) 2 (5.3) 10 (23.3) 3 (6.7) 0.064 
   Poly Margarine  3 (21.4) 5 (20.0) 9 (23.7) 15 (34.9) 9 (20.0) 0.550 
   Mono Marg  3 (21.4) 0 (0.0) 0 (0.0) 3 (7.0) 1 (2.2) 0.011 
   Marg blends  0 (0.0) 0 (0.0) 6 (15.8) 3 (7.0) 6 (13.3) 0.136 
   Butter  4 (28.6) 6 (24.0) 5 (13.2) 6 (13.9) 24 (53.3) <0.001 
   All categories  14 (100.0) 25 (100.0) 38 (100.0) 43 (100.0) 45 (100.0)  
1
Using mixed effects regression with adjustment for energy intake. 
2
Using Fishers Exact. Values in bold indicate statistical significance 
(p=0.001) compared to Profile 1.
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Table 7A: Univariate and multivariate mixed effects regression analysis for the 
Augmentation index (n=81 subjects, 140 records). 
 Univariate analysis 
β (95% CI) 
 
p-value 
Multivariate analysis 
β (95% CI) 
 
p-value
1
 
Latent profile 
   Profile 1  
 
-4.25 (-9.9, 1.4) 
0.60 
0.14 
 
-7.18 (-11.5, -2.9) 
0.023
2
 
0.001 
   Profile 2  -2.18 (-6.78, 2.43) 0.35 -1.32 (-5.38, 2.75) 0.526 
   Profile 3  Reference - Reference - 
   Profile 4 -0.49 (-4.49, 3.52) 0.81 -2.19 (-5.41, 1.02) 0.182 
   Profile 5 -1.15 (-5.24, 2.94) 0.58 -2.62 (-6.10, 0.86) 0.139 
Age (years) 0.117 (0.010, 0.225) 0.032 0.118 (0.012, 0.224)     0.028 
Gender (Female vs Male) 6.50 (3.48, 9.51) <0.001 9.19 (6.13, -12.25) <0.001 
Body mass index (kg/m2) 0.221 (-0.009, 0.450) 0.021 0.238 (0.036, 0.440) 0.021 
Health Insurance (Yes) 1.015 (-1.35, 3.38) 0.40 2.89 (0.64, 5.13) 0.012 
Fish oil supplementation -2.254 (-4.983, 0.475) 0.106 -4.15 (-6.73, -1.56) 0.002 
DAS28; Disease activity score for 28 joints. 1Using mixed effects linear regression that 
included the listed variables and also use of prednisolone, use of ibuprofen, use of folic acid, 
use of methotrexate, visit (baseline versus 8 months), energy intake, hours of physical 
activity, marital status, income and education. 2Overall association for latent profile. 
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Table 7B: Univariate and multivariate mixed effects regression analysis for log10-transformed 
CRP (n=86 subjects, 155 records).  
 Univariate analysis 
β (95% CI) 
 
p-value 
Multivariate analysis 
β (95% CI) 
 
p-value
1
 
Latent profile 
   Profile 1  
 
0.10 (-0.39, 0.59) 
 
0.69 
 
0.12 (-0.30, 0.54) 
0.892 
0.57 
   Profile 2  0.11 (-0.29, 0.51) 0.60 -0.04 (-0.43, 0.34) 0.82 
   Profile 3  Reference - Reference - 
   Profile 4 0.06 (-0.29, 0.41) 0.73 0.10 (-0.20, 0.40) 0.53 
   Profile 5 0.07 (-0.28, 0.42) 0.71 0.02 (-0.31, 0.35) 0.90 
Age (years) 0.004 (-0.005, 0.014) 0.354 -0.003 (-0.014, 0.007)      0.51 
Gender (Female vs Male) -0.26 (-0.54, 0.01) 0.057 -0.24 (-0.53, -0.03) 0.08 
DAS28 0.17 (0.09, 0.25) <0.001 0.22 (0.12, 0.31) <0.001 
Marital status     
   Married Reference - Reference - 
   Divorced/Separated -0.16 (-0.51, 0.18) 0.35 -0.30 (-0.61, 0.01) 0.06 
   Widowed 0.24 (-0.09, 0.58) 0.16 0.31 (-0.04, 0.67) 0.08 
   Never Married -0.17 (-0.57, 0.24) 0.42 -0.21 (-0.59, 0.17) 0.28 
DAS28; Disease activity score for 28 joints. 
1
Using mixed effects linear regression that 
included the listed variables and also BMI, use of prednisolone, use of ibuprofen, use of folic 
acid, use of methotrexate, visit (baseline versus 8 months), use of fish oil, energy intake, 
hours of physical activity, health insurance status, income, and level of education.
 2
Overall 
association for latent profile. 
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Table 7C: Univariate and multivariate mixed effects regression analysis for the 
Augmentation index and individual fatty acids (n=81 subjects, 140 records). 
 
 
Univariate analysis 
β (95% CI) 
 
p-value 
Multivariate analysis 
β (95% CI) 
 
p-value
1
 
8:0 Caprylic acid -4.95 (-12.8, 2.9) 0.216 -3.61 (-15.5, 8.3) 0.552 
10:0 Caproic acid -2.86 (-7.45, 1.74) 0.223 -1.84 (-5.89, 5.21) 0.609 
12:0 Lauric acid -1.01 (-2.78, 0.75) 0.259 -0.80 (-3.22, 1.61) 0.515 
14:0 Myristic acid -0.59 (-1.50, 0.31) 0.199 -0.45, (-2.01, 1.10) 0.567 
16:0 Palmitic acid -0.12 (-0.34, 0.09) 0.257 0.03 (-0.51, 0.57) 0.911 
18:0 Stearic acid -0.19 (-0.56, 0.18) 0.314 0.08 (-0.61, 0.77)      0.820 
16:1 Palmitoleic acid -0.98 (-2.99, 1.03) 0.338 1.56 (-1.81, 4.94) 0.364 
18:1 Oleic acid -0.08 (-0.23, 0.06) 0.257 -0.01 (-0.35, 0.34) 0.967 
18:2 Linoleic acid -0.25 (-0.67, 0.17) 0.237 -0.28 (-0.83, 0.26) 0.307 
18:1; trans -2.09 (-5.87, 1.69) 0.278 -4.00 (-8.14, 0.14) 0.059 
18:2; trans 23.4 (-121, 168) 0.751 38.9 (-85.6, 162) 0.537 
20:4 n-6 (AA) -20.2 (-50.9, 10.5) 0.197 -23.4 (-53.20, 6.39) 0.124 
18:3 n-3 (LA) -2.16 (-5.92, 1.61) 0.261 -4.43 (-11.2, 2.30) 0.197 
20:5 n-3 (EPA) -5.15 (-13.4, 3.07) 0.219 -6.09 (-12.9, 0.76) 0.082 
22:6 n-3 (DHA) -2.64 (-6.81, 1.52) 0.214 -3.18 (-6.67, 0.31) 0.074 
1With adjustment for age, gender,  DAS28, marital status,  BMI, use of prednisolone, use of 
ibuprofen, use of folic acid, use of methotrexate, visit (baseline versus 8 months), use of fish 
oil, energy intake, hours of physical activity, health insurance status, income, and level of 
education.  
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Figure 1 title: Standardised energy-adjusted1 mean fatty acid intake by latent profile 
membership (n=86).  
Figure 1 legend 
1Using separate multivariate linear regression models for each fatty acid regressed on energy 
intake. * Indicates significantly different to profiles 2, 3, 4 and 5 (p<0.001 for each except 
p=0.007 for 16:1 profile 3 vs profile 1). 
 
Figure 2 title: Fatty-acid intakes for each individual and mean intake for each profile (n=86). 
Figure 2 legend 
Dotted lines indicate individuals and thicker continuous line indicates mean  intake for the 
profile.  
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1Using separate multivariate linear regression models for each fatty acid regressed on energy intake. * 
Indicates significantly different to profiles 2, 3, 4 and 5 (p<0.001 for each except p=0.007 for 16:1 profile 3 
vs profile 1).  
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Dotted lines indicate individuals and thicker continuous line indicates mean  intake for the profile.  
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